Evidence Repository - Clinical Genome Resources

The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

Link to SEPIO compliant JSON-LD document

Variant: NM_000277.2(PAH):c.719T>C (p.Phe240Ser)

CA229715

102802 (ClinVar)

Gene: PAH

Condition: phenylketonuria

Inheritance Mode: Autosomal recessive inheritance

Link to MONDO

UUID: 40c992e0-e990-4d77-850d-2ded8efbba8f

HGVS expressions

NM_000277.2:c.719T>C

NM_000277.2(PAH):c.719T>C (p.Phe240Ser)

NC_000012.12:g.102852938A>G

CM000674.2:g.102852938A>G

NC_000012.11:g.103246716A>G

CM000674.1:g.103246716A>G

NC_000012.10:g.101770846A>G

NG_008690.1:g.69665T>C

NG_008690.2:g.110473T>C

ENST00000553106.6:c.719T>C

ENST00000307000.7:c.704T>C

ENST00000549247.6:n.478T>C

ENST00000553106.5:c.719T>C

NM_000277.1:c.719T>C

NM_001354304.1:c.719T>C

NM_000277.3:c.719T>C

NM_001354304.2:c.719T>C

NM_000277.3(PAH):c.719T>C (p.Phe240Ser)

Likely Pathogenic

PM3 PM2 PP4 PP3

PM5

Evidence Links 1

Expert Panel

Phenylketonuria VCEP

Criteria Specification Information

Criteria Specifications for this VCEP

Evidence submitted by expert panel

Phenylketonuria VCEP

The c.719T>C (p.Phe240Ser) variant in PAH has been reported in 1 individual with classic PKU detected with pathogenic variant p.R261Q (PMID: 11139255). This variant is absent in population databases. Computational evidence supports a deleterious effect. In summary, this variant meets criteria to be classified as likely pathogenic for PAH. PAH-specific ACMG/AMP criteria applied: PM2, PM3, PP3, PP4.

PM3

Detected with R261Q, Path/LP, maternally inherited PMID: 11139255

F240S seen in trans with R261Q (VarID 582, Pathogenic/Likely Pathogenic). IVS2+19T>C polymorphism (VarID 92736, benign) occurred in cis to the F240S mutation, as the mother had these substitutions in the same status. PubMed:11139255

PM2

Absent from ExAC, gnomAD, 1000G, ESP

PP4

c.719T>C seen in 1 patient with classic PKU. BH4 deficiency not excluded. PMID: 11139255

These mutations were detected during the characterization of the PAH genotypes of 115 patients with PKU from the southeast region of Brazil. The patients were identified by a neonatal screening program and were considered to have PKU when the phenylalanine levels were above 4 mg/dl. c.719T>C was seen in 1 patient with classic PKU. PubMed:11139255

PP3

Predicted deleterious in SIFT, Polyphen2, MutationTaster. REVEL=0.969.

PM5

F240V, no clnical significance provided in ClinVar, US by PAH VCEP

Approved on: 2020-11-09

Published on: 2022-02-20

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.